View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

NSF subsidiary withdraws designation application for European IVD and MDR

NSF International’s medical devices programme in Europe is shifting senior leadership roles and responsibilities after a subsidiary of the global public health organisation withdrew its notified body designation application for European in-vitro diagnostic (IVD) and medical device regulations (MDR).

The move by NSF Certification Ireland paves the way for the NSF’S medical device regulation experts to provide consulting and training services through NSF International in Europe.

Executive vice-president of consulting services at NSF International Medical Device said James Pink said: “Within the health products and pharma biotech sectors, NSF’s greatest strengths are in the areas of consulting and training.

“Consistent with our public health mission, we believe we can have the greatest impact on health and safety by focusing on science-based risk management solutions.”

To support the move, several NSF Certification Ireland leaders are taking on new roles within NSF International’s medical devices group, including:

  • James Pink now serves as executive vice-president of consulting services
  • Robyn Meurant now serves as executive director of the regulatory team, IVDs and medical devices
  • Laurence Matheron now serves as director of the regulatory team, IVDs and medical devices
  • Nathan Wright serves as projects specialist

NSF Pharma Biotech's CEO Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.
Making a case for good manufacturing practice (GMP) certification of an excipient manufacturer should be a straightforward exercise since the benefits appear so clear cut...
Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs) lies in allowing market access to IVDs that offer clinical...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology